Immusoft is the world leader in the development of B cells as biofactories for therapeutic protein delivery, pioneering a novel approach called Immune System Programming (ISP™) to program B cells to produce personalized protein therapeutics for patients with rare diseases
Immusoft is the world leader in the development of B cells as biofactories for therapeutic protein delivery, pioneering a novel approach called Immune System Programming (ISP™) to program B cells to produce personalized protein therapeutics for patients with rare diseases.
Immusoft is the world leader in the development of B cells as biofactories for therapeutic protein delivery, pioneering a novel approach called Immune System Programming (ISP™) to program B cells to produce personalized protein therapeutics for patients with rare diseases
Immusoft is the world leader in the development of B cells as biofactories for therapeutic protein delivery, pioneering a novel approach called Immune System Programming (ISP™) to program B cells to produce personalized protein therapeutics for patients with rare diseases.